These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9150854
1. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension. Sekiyama T, Komeichi H, Nagano T, Ohsuga M, Terada H, Katsuta Y, Satomura K, Aramaki T. Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854 [Abstract] [Full Text] [Related]
3. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis. Fierbinteanu-Braticevici C, Udeanu M, Dragomir P, Andronescu D. Rom J Intern Med; 2003 Apr; 41(3):247-54. PubMed ID: 15526508 [Abstract] [Full Text] [Related]
7. Carvedilol or propranolol in portal hypertension? A randomized comparison. Hobolth L, Møller S, Grønbæk H, Roelsgaard K, Bendtsen F, Feldager Hansen E. Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315 [Abstract] [Full Text] [Related]
8. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J, Kravetz D, Rodes J. Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [Abstract] [Full Text] [Related]
17. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis. Sugano S, Kawafune T, Suzuki T, Kubota M, Okajima T, Sumino Y, Akita H. Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089 [Abstract] [Full Text] [Related]